Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-08-29 Purchase(A) | 2023-08-31 11:26 am | Skye Bioscience Inc. | SKYE | DHILLON PUNIT Chief Executive Officer | 881,000 | $0.0187 | $16,475 | 30,272,724 (Indirect Direct) | View |
| 2023-08-29 Purchase | 2023-08-29 6:39 pm | Skye Bioscience Inc. | SKYE | DHILLON PUNIT Chief Executive Officer | 881,000 | $0.0187 | $16,475 | 43,807,874 (Direct) | View |
| 2020-08-07 Purchase(M) | 2020-08-11 2:53 pm | Emerald Bioscience Inc. | EMBI | DHILLON PUNIT CEO | 1,000,000 | $0.1 | $100,000 | 10,200,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-29 Option Award(A) | 2024-03-04 06:13 am | N/A 2034-03-01 | Skye Bioscience Inc. | SKYE | DHILLON PUNIT Chief Executive Officer | 225,000 | $0 | 522,006 (Direct) | View |
| 2024-02-29 Option Award | 2024-03-01 6:24 pm | N/A 2034-03-01 | Skye Bioscience Inc. | SKYE | DHILLON PUNIT Chief Executive Officer | 225,000 | $0 | 522,006 (Direct) | View |
| 2023-11-06 Option Award | 2023-11-06 8:29 pm | N/A 2033-08-25 | Skye Bioscience Inc. | SKYE | DHILLON PUNIT Chief Executive Officer | 215,856 | $0 | 327,605 (Direct) | View |
| 2023-08-25 Option Award(A) | 2023-08-31 11:26 am | N/A 2033-08-25 | Skye Bioscience Inc. | SKYE | DHILLON PUNIT Chief Executive Officer | 22,530,460 | $0 | 30,272,724 (Direct) | View |
| 2023-08-23 Acquisition(A) | 2023-08-31 11:26 am | N/A N/A | Skye Bioscience Inc. | SKYE | DHILLON PUNIT Chief Executive Officer | 9,000 | $0.0118 | 30,272,724 (Direct) | View |
| 2023-08-28 Acquisition(A) | 2023-08-31 11:26 am | N/A N/A | Skye Bioscience Inc. | SKYE | DHILLON PUNIT Chief Executive Officer | 110,000 | $0.0171 | 30,272,724 (Direct) | View |
| 2023-08-25 Option Award | 2023-08-29 6:39 pm | N/A 2033-08-25 | Skye Bioscience Inc. | SKYE | DHILLON PUNIT Chief Executive Officer | 22,530,460 | $0 | 43,807,874 (Direct) | View |
| 2023-08-23 Acquisition | 2023-08-29 6:39 pm | N/A N/A | Skye Bioscience Inc. | SKYE | DHILLON PUNIT Chief Executive Officer | 9,000 | $0.0118 | 43,807,874 (Direct) | View |
| 2023-08-28 Acquisition | 2023-08-29 6:39 pm | N/A N/A | Skye Bioscience Inc. | SKYE | DHILLON PUNIT Chief Executive Officer | 110,000 | $0.0171 | 43,807,874 (Direct) | View |
| 2022-11-10 Option Award | 2022-11-15 1:41 pm | N/A 2024-04-03 | Skye Bioscience Inc. | SKYE | DHILLON PUNIT Chief Executive Officer | 5,302,264 | $0 | 8,302,264 (Direct) | View |
| 2022-11-10 Option Award | 2022-11-10 9:54 pm | N/A 2032-11-10 | Arch Therapeutics Inc. | ARTH | DHILLON PUNIT Director | 250,000 | $0 | 250,000 (Direct) | View |
| 2021-12-14 Option Award | 2021-12-16 7:03 pm | N/A 2031-12-14 | Skye Bioscience Inc. | SKYE | DHILLON PUNIT Chief Executive Officer | 5,090,000 | $0 | 6,090,000 (Direct) | View |
| 2021-09-27 Option Award | 2021-10-01 08:11 am | N/A 2031-09-26 | Arch Therapeutics Inc. | ARTH | DHILLON PUNIT Director | 500,000 | $0 | 500,000 (Direct) | View |
| 2020-08-07 Option Award | 2020-08-11 2:53 pm | N/A N/A | Emerald Bioscience Inc. | EMBI | DHILLON PUNIT CEO | 9,000,000 | $0 | 10,200,000 (Direct) | View |
| 2019-12-20 Option Award | 2019-12-23 08:32 am | N/A 2029-12-19 | Arch Therapeutics Inc. | ARTH | DHILLON PUNIT Director | 300,000 | $0 | 300,000 (Direct) | View |